Virtual Colonoscopy Software Market Report 2026

The virtual colonoscopy software market size has grown strongly in recent years. It will grow from $36.03 billion in 2025 to $38.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing colorectal cancer screening initiatives, expansion of diagnostic imaging centers, growing use of CT imaging in diagnostics, rising awareness of non-invasive procedures, improvements in imaging software capabilities.

The virtual colonoscopy software market size is expected to see strong growth in the next few years. It will grow to $51.62 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of ai-powered diagnostic tools, rising investments in preventive healthcare, expansion of cloud-based medical imaging, growing demand for early cancer detection, increasing integration with hospital information systems. Major trends in the forecast period include increasing adoption of 3D virtual colonoscopy imaging, rising use of AI-assisted polyp detection, growing deployment of cloud-based imaging platforms, expansion of non-invasive screening programs, enhanced focus on diagnostic accuracy and workflow efficiency.

The increasing incidence of colorectal cancer is expected to drive the growth of the virtual colonoscopy software market going forward. Colorectal cancer is a type of cancer that develops in the tissues of the colon or rectum. Virtual colonoscopy software plays a critical role in colorectal cancer management by providing a minimally invasive and non-invasive method for screening and detecting abnormalities in the colon. For instance, in June 2023, according to the National Cancer Institution, a UK-based government agency, new cases of colorectal cancer in people under the age of 50 have been rising at an alarming rate over the past several decades, affecting more than 5,000 people diagnosed before age 50, referred to as early-onset colorectal cancer, compared with over 22,000 people without cancer (controls). Therefore, the increasing incidence of colorectal cancer is driving the growth of the virtual colonoscopy software market.

Major companies operating in the virtual colonoscopy software market are focusing on leveraging innovative solutions, such as turnkey access models, to expand non-invasive colorectal cancer screening and improve patient outcomes. Turnkey access models are comprehensive, ready-to-deploy virtual colonoscopy platforms that integrate imaging, workflow management tools, and standardized procedures, allowing healthcare facilities to implement screening services efficiently and quickly. For instance, in November 2024, Bracco Diagnostics Inc., an Italy-based diagnostic imaging company, partnered with ColoWatch, a US-based virtual colonoscopy services provider, to expand access to virtual colonoscopy for the early detection of colon and rectal cancer. This collaboration combines Bracco’s imaging expertise with ColoWatch’s standardized virtual colonoscopy methodology to provide a unified solution that enables clinics to deliver scalable, consistent, and patient-friendly colorectal screening services. By streamlining adoption across imaging centers, the partnership enhances early cancer detection accessibility, supports efficient clinical workflows, and ensures a consistent, high-quality patient experience.

In March 2023, Nvidia Corporation, a US-based software company, partnered with Medtronic PLC to develop new artificial intelligence technology for Medtronic's colorectal polyp-detection software, GI Genius. The collaboration integrates Nvidia's AI technologies into the GI Genius intelligent endoscopy module to improve its real-time capability to detect colorectal adenomas and polyps on the colon lining during colonoscopy procedures. Medtronic PLC is a US-based medical device company specializing in the development and manufacturing of medical devices and therapies.

Major companies operating in the virtual colonoscopy software market are Hitachi Medical Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Carestream Health, Agfa Healthcare, Intelerad Medical Systems Incorporated, Canon Medical Informatics Inc., TeraRecon Inc., iCAD Inc., Median Technologies, Pie Medical Imaging, Ziosoft USA Inc., Intrasense SA, Medweb, Viatronix Inc., Fujifilm Holdings Corporation, Infervision, Rendoscopy AG, Radi Insight 3D, Neusoft Medical Systems.

North America was the largest region in the virtual colonoscopy software market in 2025. The regions covered in the virtual colonoscopy software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virtual colonoscopy software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the virtual colonoscopy software market by increasing costs of imported imaging hardware, high-performance computing components, and specialized software licenses. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on advanced imported imaging infrastructure, while Asia-Pacific faces higher system deployment costs. These tariffs are raising capital investment requirements and delaying software upgrades. However, they are also encouraging domestic software development, regional imaging partnerships, and increased adoption of cloud-native diagnostic platforms.

The virtual colonoscopy software market research report is one of a series of new reports that provides virtual colonoscopy software market statistics, including virtual colonoscopy software industry global market size, regional shares, competitors with a virtual colonoscopy software market share, detailed virtual colonoscopy software market segments, market trends and opportunities, and any further data you may need to thrive in the virtual colonoscopy software industry. This virtual colonoscopy software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Virtual colonoscopy software refers to scanning and advanced imaging software that uses computed tomography to generate 2D and 3D images of the colon. This software is important for colorectal cancer screening and detection, providing a less invasive alternative to traditional colonoscopy.

The main types of products in virtual colonoscopy software are two-dimensional (2D) and three-dimensional (3D). Two-dimensional (2D) refers to objects or shapes that have only length and width and exist on a flat plane. 2D products play a key role in virtual colonoscopy software, aiding in the detection and examination of colorectal abnormalities. They can be deployed on-premises or in the cloud for applications such as polyps, Crohn’s disease, ulcerative colitis, colorectal cancer (CRC), diverticulosis, and stenosis. End users include hospitals, clinics, diagnostic centers, and ambulatory surgical centers.

The virtual colonoscopy software market includes revenues earned by entities by providing services such as colonoscopy imaging, image analysis, interpretation, reporting and documentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.